Medical Journals

Inhibition of Aldehyde Dehydrogenase and Retinoid Signaling Induces the Expansion of Human Hematopoietic Stem Cells.

Authors:
  • Chute John P
  • Muramoto Garrett G
  • Whitesides John
  • Colvin Michael
  • Safi Rachid
  • Chao Nelson J
  • McDonnell Donald P

From: Division of Cellular Therapy, Duke University Medical Center, Durham, NC 27710, USA. john.chute@duke.edu

Proceedings of the National Academy of Sciences of the United States of America

  • Publish Date: Aug 2006
  • ISSN: 0027-8424
  • Volume: 103
  • Issue: 31
  • Pages: 11707-12
  • Medium: Print
  • Language: English
  • Citation (JAMA): Chute John P, Muramoto Garrett G, Whitesides John, et al. Inhibition of Aldehyde Dehydrogenase and Retinoid Signaling Induces the Expansion of Human Hematopoietic Stem Cells.. Proc. Natl. Acad. Sci. U.S.A. Aug 2006;103:11707-12

Abstract

Aldehyde dehydrogenase (ALDH) is an enzyme that is expressed in the liver and is required for the conversion of retinol (vitamin A) to retinoic acids. ALDH is also highly enriched in hematopoietic stem cells (HSCs) and is considered a selectable marker of human HSCs, although its contribution to stem cell fate remains unknown. In this study, we demonstrate that ALDH is a key regulator of HSC differentiation. Inhibition of ALDH with diethylaminobenzaldehyde (DEAB) delayed the differentiation of human HSCs that otherwise occurred in response to cytokines. Moreover, short-term culture with DEAB caused a 3.4-fold expansion in the most primitive assayable human cells, the nonobese diabetic/severe combined immunodeficiency mouse repopulating cells, compared with day 0 CD34(+)CD38(-)lin(-) cells. The effects of DEAB on HSC differentiation could be reversed by the coadministration of the retinoic acid receptor agonist, all-trans-retinoic acid, suggesting that the ability of ALDH to generate retinoic acids is important in determining HSC fate. DEAB treatment also caused a decrease in retinoic acid receptor-mediated signaling within human HSCs, suggesting directly that inhibition of ALDH promotes HSC self-renewal via reduction of retinoic acid activity. Modulation of ALDH activity and retinoid signaling is a previously unrecognized and effective strategy to amplify human HSCs.

Mesh Headings (Keywords): Aldehyde Dehydrogenase, Animals, Antigens, CD, Cell Differentiation, Cells, Cultured, Hematopoietic Stem Cells, Homeodomain Proteins, Humans, Isoenzymes, Mice, Mice, SCID, Retinoids, Signal Transduction, Transcription Factors, p-Aminoazobenzene


Check for Full Text / PubMed Unique Identifier (PMID): 16857736


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.